Concepedia

Publication | Closed Access

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

2.2K

Citations

32

References

2007

Year

References

YearCitations

Page 1